Tumour suppressor ABCA8 inhibits malignant progression of colorectal cancer via Wnt/β-catenin pathway
Digestive and Liver Disease · 2024
DOI: 10.1016/j.dld.2023.10.026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive and Liver Disease, 2024. Verfasst von Kun Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China. Hauptthemen laut MEDLINE: Apoptosis, ATP-Binding Cassette Transporters, Colorectal Neoplasms, Wnt Signaling Pathway. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 56 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Colorectal cancer (CRC) is one of the most commonly diagnosed malignant tumours of the digestive tract, and new therapeutic targets and prognostic markers are still urgently required. However, the role and molecular mechanisms of ATP binding cassette subfamily A member 8 (ABCA8) in CRC remain unclear. METHODS: Databases and clinical specimens were analysed to determine the expression level of ABCA8 in CRC. Colony formation, CCK-8 and Transwell assays were conducted to determine cell proliferation, viability, migration and invasion. Flow cytometry was used to detect cell cycle progression and apoptosis. Western blot and rescue experiments were performed to determine the specific mechanisms of action of ABCA8. RESULTS: ABCA8 expression is dramatically down-regulated in CRC tissues and cell lines. Ectopic expression of ABCA8 induced apoptosis and cell cycle arrest in vitro, inhibited cell growth, suppressed migration and invasion, reversed epithelial-mesenchymal transition and suppressed xenograft tumour growth and metastasis in vivo. Mechanistically, ABCA8 inhibited CRC cell proliferation and metastasis through the Wnt/β-catenin signalling pathway, both in vitro and in vivo. CONCLUSION: We verified that ABCA8 inhibits the malignant progression of CRC through the Wnt/β-catenin pathway. This newly discovered ABCA8-Wnt-β-catenin signalling axis is probably helpful in guiding the clinical diagnosis and treatment of CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
- Department of Respiratory Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou Province, 563000, China.
- Department of Gastroenterology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China. Electronic address: jiangz1753@tom.com.
Zitieren
APA
Yang, K., Li, X., Jiang, Z., Li, J., Deng, Q., He, J., Chen, J., Li, X., Xu, S., & Jiang, Z. (2024). Tumour suppressor ABCA8 inhibits malignant progression of colorectal cancer via Wnt/β-catenin pathway. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2023.10.026
Vancouver
Yang K, Li X, Jiang Z, Li J, Deng Q, He J, et al. Tumour suppressor ABCA8 inhibits malignant progression of colorectal cancer via Wnt/β-catenin pathway. Digestive and Liver Disease. 2024. doi:10.1016/j.dld.2023.10.026
BibTeX
@article{Yang2024,
author = {Yang, Kun and Li, Xiaolu and Jiang, Zhongxiang and Li, Junfeng and Deng, Qianxi and He, Jin and Chen, Jun and Li, Xiaoqing and Xu, Shuman and Jiang, Zheng},
title = {Tumour suppressor ABCA8 inhibits malignant progression of colorectal cancer via Wnt/β-catenin pathway},
journal = {Digestive and Liver Disease},
year = {2024},
doi = {10.1016/j.dld.2023.10.026}
}
EUVIMED